SBI Securities »

Quince Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Quince Therapeutics shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $13 135 0.10

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Tesla Motors (TSLA)
Alphabet Inc Class A cs (GOOGL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
SPDR Gold MiniShares Trust Etf (GLDM)
Alphabet Inc Class C cs (GOOG)

View all positions for SBI Securities

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Gen-Wealth Partners
Catalyst Funds Management Pty
Fortitude Family Office
Parallel Advisors
SBI Securities

View all funds holding Quince Therapeutics